| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/29/2012 | US20120076783 Reduced-viscosity concentrated protein formulations |
| 03/29/2012 | US20120076773 Novel Drug Delivery Devices |
| 03/29/2012 | US20120076740 Water soluble pharmaceutical compositions of hops resins |
| 03/29/2012 | US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases |
| 03/29/2012 | US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 03/29/2012 | CA2812449A1 Oxadiazole inhibitors of leukotriene production |
| 03/29/2012 | CA2812362A1 Matrix metalloproteinase inhibitors |
| 03/29/2012 | CA2812361A1 Matrix metalloproteinase inhibitors |
| 03/29/2012 | CA2811895A1 Cyclopropane compounds |
| 03/28/2012 | EP2433622A1 Agent for the prophylaxis and treatment of highly pathogenic infectious diseases |
| 03/28/2012 | EP2432781A1 Salts of tiotropium with 10-camphorsulfonic acid |
| 03/28/2012 | EP2432553A2 Liquid dosage forms of isotretinoin |
| 03/28/2012 | EP2313404B1 Quinuclidine carbonate derivatives and medicinal composition thereof |
| 03/28/2012 | EP1988915B1 Tumstatin for the treatment of conditions associated with airway tissue remodeling |
| 03/28/2012 | EP1978990B1 Compositions comprising igbpma and uses thereof |
| 03/28/2012 | EP1453508B1 Tempamine compositions and use against cellular oxidative damage |
| 03/28/2012 | EP1308438B9 3-substituted urea derivatives and medicinal use thereof |
| 03/28/2012 | CN1939430B Dispersing tablets for clearing heat,purging fire and detoxifying |
| 03/28/2012 | CN102395589A Fused pyrrolopyridine derivative |
| 03/28/2012 | CN102395586A TRiazolopyridine derivatives as p38 map kinase inhibitors |
| 03/28/2012 | CN102395575A P38map kinase inhibitor |
| 03/28/2012 | CN102391279A Methyl 3,4-seco-4-hydroxy-3-cimigenolate, medicinal composition containing same and preparation method and application thereof |
| 03/28/2012 | CN102391171A Novel Substituted 3-Sulfur Indoles |
| 03/28/2012 | CN102389565A Medicament for treating or preventing animal disease |
| 03/28/2012 | CN102389538A Traditional Chinese medicine capsule preparation for treating nasopharyngitis |
| 03/28/2012 | CN102389527A Chinese medicinal composition for repairing human-body internal organs |
| 03/28/2012 | CN102389526A Vacuum freeze-drying method of rhizoma polygonatum |
| 03/28/2012 | CN102389520A Chinese medicinal composition for treating chronic bronchitis |
| 03/28/2012 | CN102389519A Traditional Chinese medicine used for treating abnormal sensations of throat |
| 03/28/2012 | CN102389518A Traditional Chinese medicine for treating chronic tonsillitis |
| 03/28/2012 | CN102389513A Processing method of polyphylla medicinal material |
| 03/28/2012 | CN102389510A Dioscorea nipponica Makino saponin extraction method |
| 03/28/2012 | CN102389500A Heat clearing and detoxifying oral solution |
| 03/28/2012 | CN102389448A Medicine for treating pharyngolaryngitis |
| 03/28/2012 | CN102389430A Application of small molecular compounds to preparation of anti-lung-cancer medicine |
| 03/28/2012 | CN102389420A Applications of indole-3-carbinol, diindolylmethane and derivatives thereof in preparation of medicaments for preventing and treating pulmonary fibrosis |
| 03/28/2012 | CN102389418A Medicine composition containing zafirlukast and statin medicine |
| 03/28/2012 | CN102389407A Application of astaxanthin in preparation of medicaments for treating and preventing pulmonary fibrosis |
| 03/28/2012 | CN102389245A Formula of health care medicine pillow for detoxifying and health-promoting |
| 03/28/2012 | CN102389234A Myrica rubra kernel health care mattress |
| 03/28/2012 | CN102018788B Drug for treating gastropathy, gastric ulcer, abdominal pain, chest distress and chronic pharyngitis, and preparation method thereof |
| 03/28/2012 | CN102018736B Natural indigo decoction piece and preparation method thereof |
| 03/28/2012 | CN101973925B 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 03/28/2012 | CN101850067B Chinese medicinal composition for treating chronic pharyngitis |
| 03/28/2012 | CN101849927B Hot-melt pressure-sensitive adhesive transdermal patch containing alpha-asarone and preparation method thereof |
| 03/28/2012 | CN101690788B Throat-clearing three dispersion granules |
| 03/28/2012 | CN101646654B Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 03/28/2012 | CN101341997B Snow pear beverage and preparation technique |
| 03/27/2012 | US8143486 Delta-5 desaturase and uses thereof |
| 03/27/2012 | US8143383 Δ-6 desaturase and uses thereof |
| 03/27/2012 | US8143313 Compositions and methods for preventing or treating an inflammatory response |
| 03/27/2012 | US8143277 Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 03/27/2012 | US8143261 Thiazolo (4,5-D) pyrimidine compounds |
| 03/27/2012 | US8143249 Prodrugs of A2B adenosine receptor antagonists |
| 03/27/2012 | US8143239 Composition for inhalation |
| 03/27/2012 | US8142778 Methods of treatment using CTLA-4 antibodies |
| 03/27/2012 | CA2709997C Pirfenidone treatment for patients with atypical liver function |
| 03/27/2012 | CA2544193C A2b adenosine receptor antagonists |
| 03/27/2012 | CA2529007C Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 03/27/2012 | CA2526991C Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 03/27/2012 | CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 03/22/2012 | WO2012037078A2 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods |
| 03/22/2012 | WO2012035548A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 03/22/2012 | WO2012035158A1 Pyrazine derivatives as enac blockers |
| 03/22/2012 | WO2012035122A1 Anthraquinone compounds and their uses |
| 03/22/2012 | US20120071657 Triazole compounds useful as protein kinase inhibitors |
| 03/22/2012 | US20120071561 Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease And Transplant Rejection |
| 03/22/2012 | US20120071554 Deuterated 2-propylpentanoic acid compounds |
| 03/22/2012 | US20120071550 Synergistic combinations of cartonoids and polyphenols |
| 03/22/2012 | US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor |
| 03/22/2012 | US20120071520 Crystalline phases of 2'--biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide |
| 03/22/2012 | US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| 03/22/2012 | US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/22/2012 | US20120071494 Pyrazolopyridine kinase inhibitors |
| 03/22/2012 | US20120071479 Pyrazine derivatives as enac blockers |
| 03/22/2012 | US20120071471 Novel benzoxazinone derivatives useful for the treatment of cns disorders |
| 03/22/2012 | US20120071469 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 03/22/2012 | US20120071467 Amide derivative |
| 03/22/2012 | US20120071461 Substituted Benzamide Compounds |
| 03/22/2012 | US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists |
| 03/22/2012 | US20120071452 Combinations comprising antimuscarinic agents and corticosteriods |
| 03/22/2012 | US20120071450 Organic compounds |
| 03/22/2012 | US20120071449 Pharmaceutical composition for inhalation |
| 03/22/2012 | US20120071442 Lipid conjugates in the treatment of chronic rhinosinusitis |
| 03/22/2012 | US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives |
| 03/22/2012 | US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN |
| 03/22/2012 | US20120071394 Novel polypeptides and use thereof |
| 03/22/2012 | US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives |
| 03/22/2012 | US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS |
| 03/22/2012 | US20120070431 Methods for treating chronic obstructive pulmonary disease |
| 03/22/2012 | US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma |
| 03/22/2012 | CA2812184A1 Anthraquinone compounds and their uses |
| 03/22/2012 | CA2811076A1 Pyrazine derivatives as enac blockers |
| 03/22/2012 | CA2810625A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 03/21/2012 | EP2431049A2 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases |
| 03/21/2012 | EP2429994A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 03/21/2012 | EP2429533A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity |
| 03/21/2012 | EP2429527A1 New combination therapy in treatment of cancer and fibrotic diseases |
| 03/21/2012 | EP2429515A1 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity |
| 03/21/2012 | EP2185588B9 Synthetic pulmonary surfactant peptides |